Neovacs to Give Update on Potential Lupus Vaccine, Now in Phase 2 Trial, at Conference
Neovacs will present an update on the company’s interferon alpha (IFNα) Kinoid vaccine program for lupus, dermatomyositis and type 1 diabetes at the upcoming 2017 Keystone Symposia Conference taking place in Banff, Alberta, Canada. Géraldine Grouard-Vogel, PhD, the company’s chief scientific officer, is set to give the presentation — “Overexpression of IFNalpha…